FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dangshe Ma

Research Profile

Chemicals & Drugs

Procedures

Objects

Alpha Particles

Living Beings

Disorders

Prostatic Neoplasms

Concepts & Ideas

Tissue Distribution

Anatomy

Co-author Network

Publications

TOP 3
Andre J Marozsan; Kirsten A Nagashima; Robert R Arrigale; Gerald P Donovan; Yun Kenneth Kang; Brian J Kennedy; Dangshe Ma; Paul J Maddon; Wells W Magargal; William C Olson
Protection against Clostridium difficile infection with broadly neutralizing antitoxin monoclonal antibodies.
Xinning Wang; Dangshe Ma; William C Olson; Warren D W Heston
In vitro and in vivo responses of advanced prostate tumors to PSMA ADC, an auristatin-conjugated antibody to prostate-specific membrane antigen.
Dangshe Ma; Christine E Hopf; Andrew D Malewicz; Gerald P Donovan; Peter D Senter; William F Goeckeler; Paul J Maddon; William C Olson
Potent antitumor activity of an auristatin-conjugated, fully human monoclonal antibody to prostate-specific membrane antigen.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dangshe Ma (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Andre J Marozsan; Kirsten A Nagashima; Robert R Arrigale; Gerald P Donovan; Yun Kenneth Kang; Brian J Kennedy; Dangshe Ma; Paul J Maddon; Wells W Magargal; William C Olson
Protection against Clostridium difficile infection with broadly neutralizing antitoxin monoclonal antibodies.
The Journal of infectious diseases 2012;206(5):706-13.
2011: Xinning Wang; Dangshe Ma; William C Olson; Warren D W Heston
In vitro and in vivo responses of advanced prostate tumors to PSMA ADC, an auristatin-conjugated antibody to prostate-specific membrane antigen.
Molecular cancer therapeutics 2011;10(9):1728-39.
2006: Dangshe Ma; Christine E Hopf; Andrew D Malewicz; Gerald P Donovan; Peter D Senter; William F Goeckeler; Paul J Maddon; William C Olson
Potent antitumor activity of an auristatin-conjugated, fully human monoclonal antibody to prostate-specific membrane antigen.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(8):2591-6.
2005: Diane E Milenic; Kayhan Garmestani; Erik D Brady; Paul S Albert; Dangshe Ma; Alia Abdulla; Martin W Brechbiel
Alpha-particle radioimmunotherapy of disseminated peritoneal disease using a (212)Pb-labeled radioimmunoconjugate targeting HER2.
Cancer biotherapy & radiopharmaceuticals 2005;20(5):557-68.
2004: Diane E Milenic; Kayhan Garmestani; Erik D Brady; Paul S Albert; Dangshe Ma; Alia Abdulla; Martin W Brechbiel
Targeting of HER2 antigen for the treatment of disseminated peritoneal disease.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(23):7834-41.
2003: Norbert Schülke; Olga A Varlamova; Gerald P Donovan; Dangshe Ma; Jason P Gardner; Donna M Morrissey; Robert R Arrigale; Cenchen Zhan; Amy J Chodera; Kenneth G Surowitz; Paul J Maddon; Warren D W Heston; William C Olson
The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(22):12590-5.
2003: Lara L Chappell; Dangshe Ma; Diane E Milenic; Kayhan Garmestani; Vincent J Venditto; Markus Beitzel; Martin W Brechbiel
Synthesis and evaluation of novel bifunctional chelating agents based on 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid for radiolabeling proteins.
Nuclear medicine and biology 2003;30(6):581-95.
2002: Michael R McDevitt; Dangshe Ma; Jim Simon; R Keith Frank; David A Scheinberg
Design and synthesis of 225Ac radioimmunopharmaceuticals.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2002;57(6):841-7.
2002: Joseph G Jurcic; Steven M Larson; George Sgouros; Michael R McDevitt; Ronald D Finn; Chaitanya R Divgi; Ase M Ballangrud; Klaus A Hamacher; Dangshe Ma; John L Humm; Martin W Brechbiel; Roger Molinet; David A Scheinberg
Targeted alpha particle immunotherapy for myeloid leukemia.
Blood 2002;100(4):1233-9.
2002: Hyun-Soon Chong; Kayhan Garmestani; Dangshe Ma; Diane E Milenic; Terrish Overstreet; Martin W Brechbiel
Synthesis and biological evaluation of novel macrocyclic ligands with pendent donor groups as potential yttrium chelators for radioimmunotherapy with improved complex formation kinetics.
Journal of medicinal chemistry 2002;45(16):3458-64.
2002: Diane E Milenic; Kayhan Garmestani; Lara L Chappell; Ekaterina Dadachova; Alexander T Yordanov; Dangshe Ma; Jeffrey Schlom; Martin W Brechbiel
In vivo comparison of macrocyclic and acyclic ligands for radiolabeling of monoclonal antibodies with 177Lu for radioimmunotherapeutic applications.
Nuclear medicine and biology 2002;29(4):431-42.
2002: Dangshe Ma; Michael R McDevitt; EC Barendswaard; L Lai; Michael J Curcio; Virginia A Pellegrini; Martin W Brechbiel; David A Scheinberg
Radioimmunotherapy for model B cell malignancies using 90Y-labeled anti-CD19 and anti-CD20 monoclonal antibodies.
Leukemia 2002;16(1):60-6.
2002: Dangshe Ma; Francis Lu; Terrish Overstreet; Diane E Milenic; Martin W Brechbiel
Novel chelating agents for potential clinical applications of copper.
Nuclear medicine and biology 2002;29(1):91-105.
2001: Michael R McDevitt; Dangshe Ma; L T Lai; J Simon; Paul E Borchardt; R K Frank; K Wu; Virginia A Pellegrini; Michael J Curcio; Miederer Matthias; Neil H Bander; David A Scheinberg
Tumor therapy with targeted atomic nanogenerators.
Science (New York, N.Y.) 2001;294(5546):1537-40.
2001: Dangshe Ma; Michael R McDevitt; Ronald D Finn; David A Scheinberg
Breakthrough of 225Ac and its radionuclide daughters from an 225Ac/213Bi generator: development of new methods, quantitative characterization, and implications for clinical use.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2001;55(5):667-78.
2001: Dangshe Ma; Michael R McDevitt; Ronald D Finn; David A Scheinberg
Rapid preparation of short-lived alpha particle emitting radioimmunopharmaceuticals.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2001;55(4):463-70.
2001: Ekaterina Dadachova; C Park; N Eberly; Dangshe Ma; Chang H Paik; Martin W Brechbiel
In vitro and in vivo characterization of 67Ga(3+) complexes with cis,cis-1,3,5-triamino-cyclohexane-N,N',N"-triacetic acid derivatives.
Nuclear medicine and biology 2001;28(6):695-701.
2001: Ase M Ballangrud; Wei-Hong Yang; D E Charlton; Michael R McDevitt; Klaus A Hamacher; Katherine S Panageas; Dangshe Ma; Neil H Bander; David A Scheinberg; George Sgouros
Response of LNCaP spheroids after treatment with an alpha-particle emitter (213Bi)-labeled anti-prostate-specific membrane antigen antibody (J591).
Cancer research 2001;61(5):2008-14.
2000: Michael R McDevitt; EC Barendswaard; Dangshe Ma; L Lai; Michael J Curcio; George Sgouros; Ase M Ballangrud; Wei-Hong Yang; Ronald D Finn; Virginia A Pellegrini; MW Geerlings; M Lee; Martin W Brechbiel; Neil H Bander; Carlos Cordon-Cardo; David A Scheinberg
An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer.
Cancer research 2000;60(21):6095-100.
1999: Michael R McDevitt; Ronald D Finn; Dangshe Ma; Steven M Larson; David A Scheinberg
Preparation of alpha-emitting 213Bi-labeled antibody constructs for clinical use.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(10):1722-7.
1999: Michael R McDevitt; Ronald D Finn; George Sgouros; Dangshe Ma; David A Scheinberg
An 225Ac/213Bi generator system for therapeutic clinical applications: construction and operation.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 1999;50(5):895-904.